Table 2.
COVID-19 incidence in the primary analytical cohort
| COLUMN ONE | BNT162b2 | Ad26.COV2.S | ||||
|---|---|---|---|---|---|---|
| At-risk Time (pt-weeks) | COVID-19 Diagnoses | Incidence Rate (95% CI) | At-risk Time (pt-weeks) | COVID-19 Diagnoses | Incidence Rate (95% CI) | |
| All pairs (n=2,572 pairs) | 51,339 | 75 | 1.46 (1.17 to 1.83) | 50,916 | 83 | 1.63 (1.31 to 2.02) |
| No prior COVID-19 (n=2304 pairs)a | 45,942 | 75 | 1.63 (1.30 to 2.05) | 45,522 | 83 | 1.82 (1.47 to 2.26) |
| Completer pairs (n=2477 pairs)b | 49,807 | 68 | 1.37 (1.08 to 1.73) | 49,181 | 81 | 1.65 (1.32 to 2.05) |
| Completer pairs with no prior COVID-19 (n=2225 pairs) | 44,632 | 68 | 1.52 (1.20 to 1.93) | 44,078 | 81 | 1.84 (1.48 to 2.28) |
a
Refers to COVID-19 diagnosis before index date (date of first vaccination).
b
Matched pairs for which the BNT162b2 member completed a two-dose series.